Bioassays that are commonly used to diagnose different subtypes of breast cancers target specific biomarkers, mostly proteins such as hormone receptors (Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), Progesterone Receptor (PR)). This evidence concerns the gene ERBB2 and breast cancer.